| Literature DB >> 26327357 |
Cornelia Köhler1, Christoph Heyer2, Sabine Hoffjan3, Susanne Stemmler3, Thomas Lücke4, Charlotte Thiels4, Alfried Kohlschütter5, Ulrike Löbel6, Rita Horvath7, Stephanie Kleinle8, Anna Benet-Pages8, Angela Abicht8.
Abstract
Mutations in the DARS2 gene are known to cause leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL), a rare autosomal recessive neurological disorder. It was originally described as juvenile-onset slowly progressive ataxia and spasticity, but recent reports suggest a broader clinical spectrum. Most patients were found to carry compound heterozygous DARS2 mutations, and only very few patients with homozygous mutations have been described so far. We present here an 8-month-old boy carrying a homozygous missense mutation in DARS2 who clinically showed severe neurological deterioration after a respiratory tract infection, followed by an almost complete remission of symptoms. This report further extends the knowledge about the clinical and molecular genetic spectrum of LBSL.Entities:
Keywords: DARS2; LBSL; Leukoencephalopathy; Magnetic resonance imaging; Mitochondriopathy
Mesh:
Substances:
Year: 2015 PMID: 26327357 DOI: 10.1016/j.mcp.2015.06.005
Source DB: PubMed Journal: Mol Cell Probes ISSN: 0890-8508 Impact factor: 2.365